These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29258267)

  • 1. cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue.
    Takaki H; Takashima K; Oshiumi H; Ainai A; Suzuki T; Hasegawa H; Matsumoto M; Seya T
    Med Sci (Basel); 2017 Dec; 5(4):. PubMed ID: 29258267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
    Pacini MF; Balbi CB; Dinatale B; González FB; Prochetto E; De Hernández MA; Cribb P; Farré C; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
    Acta Trop; 2023 May; 241():106889. PubMed ID: 36893830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses.
    Zuercher AW; Coffin SE; Thurnheer MC; Fundova P; Cebra JJ
    J Immunol; 2002 Feb; 168(4):1796-803. PubMed ID: 11823512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen.
    Mizuno D; Ide-Kurihara M; Ichinomiya T; Kubo I; Kido H
    J Immunol; 2006 Jan; 176(2):1122-30. PubMed ID: 16394001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages.
    Lee E; Jang HE; Kang YY; Kim J; Ahn JH; Mok H
    Acta Biomater; 2016 Jan; 29():271-281. PubMed ID: 26485167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
    Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
    Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
    Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles.
    Shim S; Soh SH; Im YB; Ahn C; Park HT; Park HE; Park WB; Kim S; Yoo HS
    PLoS One; 2020; 15(2):e0228463. PubMed ID: 32027689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination.
    Takeda Y; Takaki H; Fukui-Miyazaki A; Yoshida S; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1019-1025. PubMed ID: 30404733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
    Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
    Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
    Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
    Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.
    Seefeld ML; Templeton EL; Lehtinen JM; Sinclair N; Yadav D; Hartwell BL
    Front Immunol; 2024; 15():1419527. PubMed ID: 39286244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method.
    Petukhova G; Naikhin A; Chirkova T; Donina S; Korenkov D; Rudenko L
    Vaccine; 2009 Apr; 27(19):2580-7. PubMed ID: 19428864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
    Asahi Y; Yoshikawa T; Watanabe I; Iwasaki T; Hasegawa H; Sato Y; Shimada S; Nanno M; Matsuoka Y; Ohwaki M; Iwakura Y; Suzuki Y; Aizawa C; Sata T; Kurata T; Tamura S
    J Immunol; 2002 Mar; 168(6):2930-8. PubMed ID: 11884464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues.
    Liu J; Stoler-Barak L; Hezroni-Bravyi H; Biram A; Lebon S; Davidzohn N; Kedmi M; Chemla M; Pilzer D; Cohen M; Brenner O; Biton M; Shulman Z
    Nature; 2024 Aug; 632(8025):637-646. PubMed ID: 39085603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
    Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura SS
    Vaccine; 2000 Jan; 18(14):1344-50. PubMed ID: 10618531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of T-cell subsets and immunoglobulin-containing cells in nasal-associated lymphoid tissue (NALT) of chickens.
    Ohshima K; Hiramatsu K
    Histol Histopathol; 2000 Jul; 15(3):713-20. PubMed ID: 10963115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.
    Aljurayyan AN; Sharma R; Upile N; Beer H; Vaughan C; Xie C; Achar P; Ahmed MS; McNamara PS; Gordon SB; Zhang Q
    Antiviral Res; 2016 Aug; 132():122-30. PubMed ID: 27247060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.